TQC3302
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 06, 2025
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=44 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.
New P1 trial • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1